SGBV
Home >>Official Listing >> Listed companies >> BIOPHARM

BIOPHARM

Type : Titre Capital
Presentation

Biopharm SPA is a diversified group operating across various segments of the pharmaceutical industry. Founded in 1991, the company has steadily grown over the past two decades by enhancing the quality standards of its production facilities and strengthening its distribution network.

In 2014, Biopharm SPA achieved consolidated revenues of 49 billion Algerian dinars, representing 13% of the national pharmaceutical market volume.

Today, Biopharm continues its growth trajectory by going public, offering Algerian national savings the opportunity to invest in a company well-positioned to pursue high-performance development within the Algerian pharmaceutical sector.

 

Chairman of the Board of Directors

Mr. Sofiane Lahmar
Specifications

Public Offering of Subscription (IPO)

Company Name: BIOPHARM

Share Capital: 5,104,375,000 Algerian dinars, divided into 25,521,875 shares with a nominal value of 200 DA each

Shares Offered: 5,104,375 shares, representing 20% of the share capital

Issue Price: 1,225 DA per share

Subscription Period: From March 13, 2016 to April 7, 2016

Financial Intermediaries
Lead Arranger (IOB): BEA

Placement Syndicate Members:

BNA, BEA, BADR, BDL, CNEP, CPA, BNP Paribas El Djazaïr, Société Générale Algérie, Tell Market's
Web site www.biopharmdz.com
Contact

Zone Industrielle – Oued Smar Lot No. 62, Road No. 36 Algiers, Algeria

Phone: +213 21 50 63 10 / 59 10 / 51 99

Fax: +213 21 50 63 96 / 50 66 87

Mob: +213 770 14 52 52